https://www.biospace.com/tae-life-sciences-secures-30m-in-initial-b-round-phase-to-accelerate-development-of-unique-boron-delivery-drugs-for-novel-cancer-treatment
Novel Small Molecule and Antibody Conjugate Approaches Expected to Enable Broad Adoption of Boron Neutron Capture Therapy
tae life sciencessecuresinitialbround
https://taelifesciences.com/
TAE Life Sciences is revolutionizing cancer research through our proprietary Boron Neutron Capture Therapy (BNCT) technology. Learn about how we seek to...
tae life sciences